| Line Item | 2026-02-01 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $19.31B | — | +29.5% |
| Cost of Revenue | $6.15B | — | +29.0% |
| Gross Profit | $13.16B | — | +29.7% |
| R&D Expense | $2.96B | — | +31.6% |
| SG&A Expense | $1.02B | — | +7.4% |
| Operating Income | $8.56B | — | +36.8% |
| Interest Expense | $801.0M | — | -8.2% |
| Pre-tax Income | $8.20B | — | +49.3% |
| Income Tax | $846.0M | — | +6607.7% |
| Net Income | $7.35B | — | +33.5% |
| EPS (Basic) | $1.55 | — | +32.5% |
| EPS (Diluted) | $1.50 | — | +31.6% |
| Line Item | 2026-02-01 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $14.17B | -12.4% | +52.3% |
| Accounts Receivable | $8.46B | +18.4% | +70.7% |
| Inventory | $2.96B | +30.5% | +55.2% |
| Current Assets | $32.06B | +1.5% | +52.7% |
| Total Assets | $169.90B | -0.7% | +2.7% |
| Current Liabilities | $16.86B |
| Line Item | 2026-02-01 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $8.26B | — | +35.1% |
| Capital Expenditures | $250.0M | — | +150.0% |
| Investing Cash Flow | -$115.0M | — | +33.9% |
| Financing Cash Flow | -$10.15B | — | -69.7% |
| Free Cash Flow | $8.01B | — | +33.2% |
| -19.4% |
| Long-term Debt | $66.06B | +1.4% | +8.4% |
| Total Liabilities | $90.03B | +0.3% | -5.8% |
| Stockholders' Equity | $79.87B | -1.7% | +14.4% |